Strengthening Health Systems; the Basis for Controlling Corona Virus Pandemics


avatar Fateme Sedghi ORCID 1 , * , avatar Mahdi Gholian Aval ORCID 2 , avatar Mohammad Vahedian Sharoodi ORCID 2

Student Research Committee, Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Department of Health Education and Health Promotion School of Health, Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

how to cite: Sedghi F, Gholian Aval M, Vahedian Sharoodi M. Strengthening Health Systems; the Basis for Controlling Corona Virus Pandemics. Health Scope. 2020;9(4):e106207.


  • 1.

    Pan X, Ojcius DM, Gao T, Li Z, Pan C, Pan C. Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases. Microbes Infect. 2020;22(2):86-91. [PubMed ID: 32088333]. [PubMed Central ID: PMC7102576].

  • 2.

    Marty AM, Jones MK. The novel Coronavirus (SARS-CoV-2) is a one health issue. One Health. 2020;9:100123. [PubMed ID: 32140538]. [PubMed Central ID: PMC7049657].

  • 3.

    Dixon S, McDonald S, Roberts J. The impact of HIV and AIDS on Africa's economic development. BMJ. 2002;324(7331):232-4. [PubMed ID: 11809650]. [PubMed Central ID: PMC1122139].

  • 4.

    Keogh-Brown MR, Smith RD. The economic impact of SARS: how does the reality match the predictions? Health Policy. 2008;88(1):110-20. [PubMed ID: 18436332]. [PubMed Central ID: PMC7114672].

  • 5.

    Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. [PubMed ID: 32081636]. [PubMed Central ID: PMC7127800].

  • 6.

    Patel A, Jernigan DB, nCo VT. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(5):140-6. [PubMed ID: 32027631]. [PubMed Central ID: PMC7004396].

  • 7.

    Bhardwaj R. Mitigating the Adverse Consequences of Pandemics: A Short Note with a Special Reference to COVID-19. SSRN Electron J. 2020.

  • 8.

    Baldwin R, Tomiura E. Thinking ahead about the trade impact of COVID-19. Economics in the Time of COVID-19. 2020;59.

  • 9.

    Raoofi A, Takian A, Akbari Sari A, Olyaeemanesh A, Haghighi H, Aarabi M. COVID-19 Pandemic and Comparative Health Policy Learning in Iran. Arch Iran Med. 2020;23(4):220-34. [PubMed ID: 32271594].

  • 10.

    De Ceukelaire W, Bodini C. We Need Strong Public Health Care to Contain the Global Corona Pandemic. Int J Health Serv. 2020;50(3):276-7. [PubMed ID: 32188308]. [PubMed Central ID: PMC7140782].

  • 11.

    Jamali D. Success and failure mechanisms of public private partnerships (PPPs) in developing countries. Int J Public Sector Manag. 2004;17(5):414-30.

  • 12.

    Sampath P, Wilson D. A case study and state of science review: private versus public healthcare financing. Glob J Health Sci. 2011;4(1):118-26. [PubMed ID: 22980105]. [PubMed Central ID: PMC4777022].

  • 13.

    Nikolic IA, Maikisch H. Public-private partnerships and collaboration in the health sector: an overview with case studies from recent European experience. 2006.

  • 14.

    Evans TG, Chowdhury AMR, Evans DB, Fidler A, Lindelow M, Mills A, et al. Thailand’s universal coverage scheme: achievements and challenges. An Independent Assessment of the First. 2012;10:2001-10.

  • 15.

    Shrivastava SRL, Shrivastava PS. Corona virus disease 2019 pandemic: Necessity for active engagement of the private sector. Dent Med Res. 2020;8(1).

  • 16.

    Arimoro A. The Corona Virus (COVID-19) Pandemic and the Challenge of Healthcare Infrastructure in Nigeria: What Role for Public-Private Partnerships. PrePrint. 2020.